These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38043703)

  • 1. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
    Wahle M; Thielert M; Zwiebel M; Skowronek P; Zeng WF; Mann M
    Mol Cell Proteomics; 2024 Jan; 23(1):100689. PubMed ID: 38043703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
    ElAbd H; Franke A
    Methods Mol Biol; 2024; 2758():425-443. PubMed ID: 38549028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.
    Phulphagar KM; Ctortecka C; Jacome ASV; Klaeger S; Verzani EK; Hernandez GM; Udeshi ND; Clauser KR; Abelin JG; Carr SA
    Mol Cell Proteomics; 2023 Jun; 22(6):100563. PubMed ID: 37142057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
    Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
    Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics.
    Lim Kam Sian TCC; Goncalves G; Steele JR; Shamekhi T; Bramberger L; Jin D; Shahbazy M; Purcell AW; Ramarathinam S; Stoychev S; Faridi P
    Front Immunol; 2023; 14():1107576. PubMed ID: 37334365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
    Pak H; Michaux J; Huber F; Chong C; Stevenson BJ; Müller M; Coukos G; Bassani-Sternberg M
    Mol Cell Proteomics; 2021; 20():100080. PubMed ID: 33845167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.
    Juanes-Velasco P; Arias-Hidalgo C; García-Vaquero ML; Sotolongo-Ravelo J; Paíno T; Lécrevisse Q; Landeira-Viñuela A; Góngora R; Hernández ÁP; Fuentes M
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of immunopeptidomics: From basic research to clinical implementation.
    Shapiro IE; Bassani-Sternberg M
    Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.
    Vizcaíno JA; Kubiniok P; Kovalchik KA; Ma Q; Duquette JD; Mongrain I; Deutsch EW; Peters B; Sette A; Sirois I; Caron E
    Mol Cell Proteomics; 2020 Jan; 19(1):31-49. PubMed ID: 31744855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOF
    Hoenisch Gravel N; Nelde A; Bauer J; Mühlenbruch L; Schroeder SM; Neidert MC; Scheid J; Lemke S; Dubbelaar ML; Wacker M; Dengler A; Klein R; Mauz PS; Löwenheim H; Hauri-Hohl M; Martin R; Hennenlotter J; Stenzl A; Heitmann JS; Salih HR; Rammensee HG; Walz JS
    Nat Commun; 2023 Nov; 14(1):7472. PubMed ID: 37978195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics.
    Wilhelm M; Zolg DP; Graber M; Gessulat S; Schmidt T; Schnatbaum K; Schwencke-Westphal C; Seifert P; de Andrade Krätzig N; Zerweck J; Knaute T; Bräunlein E; Samaras P; Lautenbacher L; Klaeger S; Wenschuh H; Rad R; Delanghe B; Huhmer A; Carr SA; Clauser KR; Krackhardt AM; Reimer U; Kuster B
    Nat Commun; 2021 Jun; 12(1):3346. PubMed ID: 34099720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
    Pyke RM; Mellacheruvu D; Dea S; Abbott C; Zhang SV; Phillips NA; Harris J; Bartha G; Desai S; McClory R; West J; Snyder MP; Chen R; Boyle SM
    Mol Cell Proteomics; 2023 Apr; 22(4):100506. PubMed ID: 36796642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Immunopeptidomics We Need a Sniper Instead of a Shotgun.
    Faridi P; Purcell AW; Croft NP
    Proteomics; 2018 Jun; 18(12):e1700464. PubMed ID: 29377634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.
    Freudenmann LK; Marcu A; Stevanović S
    Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
    Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
    J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery.
    Stutzmann C; Peng J; Wu Z; Savoie C; Sirois I; Thibault P; Wheeler AR; Caron E
    Cell Rep Methods; 2023 Jun; 3(6):100511. PubMed ID: 37426761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
    Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
    J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
    Ghosh M; Gauger M; Marcu A; Nelde A; Denk M; Schuster H; Rammensee HG; Stevanović S
    Mol Cell Proteomics; 2020 Mar; 19(3):432-443. PubMed ID: 31937595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery.
    Zhang B; Bassani-Sternberg M
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery.
    Ritz D; Gloger A; Neri D; Fugmann T
    Proteomics; 2017 Jan; 17(1-2):. PubMed ID: 27862975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.